Status:

UNKNOWN

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Lead Sponsor:

Sun Yat-sen University

Conditions:

Non-small Cell Lung Cancer

Breast Cancer

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

As cytotoxic agents, DTX and PTX have a narrow therapeutic window. BSA dosing leads to great inter-individual PK variability, which is a major contributor for severe toxicity, especially in East-Asian...

Detailed Description

3 populations were included: advanced NSCLC patients receive a single-agent docetaxel regimen palliative chemotherapy without restriction of lines; NPC patients receive paclitaxel and carboplatin doub...

Eligibility Criteria

Inclusion

  • Confirmed by pathology for advanced non small cell lung cancer, suitable for paclitaxel or docetaxel chemotherapy (clinical stage IV according to 2009 IASLC staging or recurrent NSCLC; receiving palliative chemotherapy independent of lines)
  • ECOG PS score: 0 to 2 points
  • Survival is expected to more than 3 month
  • Bone marrow reserve function is good, the function of organs (liver and kidney) is good, can satisfy the conditions of implementation chemotherapy.
  • Sign the informed consent form
  • Compliance is good, can be followed up, willing to comply with the requirements of the study

Exclusion

  • Physical status score (ECOG) greater than 2
  • organic disease;Severely active infection;Organ transplantation immune therapy;Can't complete with in four to six cycles of chemotherapy
  • Bone marrow, liver and kidney dysfunction, clinical doctors identify intolerance to chemotherapy

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2016

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT01891123

Start Date

June 1 2013

End Date

December 1 2016

Last Update

December 9 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, China, 510030